Software Engineer, Applications & Systems
Merge Labs1 month ago
Base Salary
$185k - $260k/yr
Responsibilities
- Build applications and interactive tools for experiment configuration, execution monitoring, result visualization, and metadata capture.
- Integrate instrument capabilities with an SDK engineer and improve shared interfaces for applications and scripts.
- Separate reusable experiment logic from presentation code to support interactive and automated workflows.
- Implement failure handling, cancellation, recovery, logging, and testing.
- Connect application outputs to data services with metadata and version information.
- Contribute to backend services, data integration, developer tooling, CI, packaging, deployment, and performance improvements.
- Diagnose issues across UI, concurrency, native code, and hardware interfaces while collaborating with specialists.
- Work with scientists and engineers to ship and iteratively improve useful tools.
- Own changes through code review, release, documentation, and follow-up.
Requirements
- Strong coding and debugging fundamentals with examples of completed software that others have used.
- Experience building applications, services, or tools and understanding adjacent system layers.
- Comfort using APIs, writing tests, version control, and code review.
- Ability to learn unfamiliar systems, ask for help early, and build trustworthy user workflows and data handling.
- Helpful but not required: experience with scientific software, robotics, instrumentation, imaging, lab automation, asynchronous systems, data pipelines, offline deployment, or hardware integration.
- Helpful but not required: Python, C++, Rust, desktop applications, or interactive visualization.
Categories
About Merge Labs
Merge Labs is a privately held research lab developing high-bandwidth brain-computer interfaces that integrate with advanced AI to augment human capability. It builds experimental platforms and automated pipelines across molecular engineering, synthetic biology, neuroscience, advanced microscopy, sequencing, and mammalian cell culture to accelerate BCI R&D. Founded in 2025, the company focuses on safe, accessible neurotechnology rather than commercial products today.